These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10395328)

  • 1. Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model.
    Husain SR; Kreitman RJ; Pastan I; Puri RK
    Nat Med; 1999 Jul; 5(7):817-22. PubMed ID: 10395328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft.
    Husain SR; Puri RK
    Blood; 2000 Jun; 95(11):3506-13. PubMed ID: 10828036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.
    Leland P; Taguchi J; Husain SR; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 2000 Mar; 6(3):165-78. PubMed ID: 10965493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein.
    Husain SR; Obiri NI; Gill P; Zheng T; Pastan I; Debinski W; Puri RK
    Clin Cancer Res; 1997 Feb; 3(2):151-6. PubMed ID: 9815666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting AIDS-Kaposi's sarcoma.
    Mesri EA
    Nat Med; 1999 Jul; 5(7):738-9. PubMed ID: 10395315
    [No Abstract]   [Full Text] [Related]  

  • 6. Chimeric protein cytotoxic against KS tumors.
    Marshall A; Castellino A
    Nat Biotechnol; 1997 Apr; 15(4):304. PubMed ID: 9094112
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased antitumor activity of a circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma.
    Kreitman RJ; Puri RK; Pastan I
    Cancer Res; 1995 Aug; 55(15):3357-63. PubMed ID: 7614471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts.
    Beseth BD; Cameron RB; Leland P; You L; Varricchio F; Kreitman RJ; Maki RA; Jablons DM; Husain SR; Puri RK
    Ann Thorac Surg; 2004 Aug; 78(2):436-43; discussion 436-43. PubMed ID: 15276492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.
    Husain SR; Gill P; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 1997 May; 3(5):327-38. PubMed ID: 9205948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy.
    Husain SR; Behari N; Kreitman RJ; Pastan I; Puri RK
    Cancer Res; 1998 Aug; 58(16):3649-53. PubMed ID: 9721874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.
    Puri RK; Hoon DS; Leland P; Snoy P; Rand RW; Pastan I; Kreitman RJ
    Cancer Res; 1996 Dec; 56(24):5631-7. PubMed ID: 8971168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy.
    Husain SR; Joshi BH; Puri RK
    Int J Cancer; 2001 Apr; 92(2):168-75. PubMed ID: 11291041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxins directed at interleukin-4 receptors as therapy for human brain tumors.
    Puri RK
    Methods Mol Biol; 2001; 166():155-76. PubMed ID: 11217365
    [No Abstract]   [Full Text] [Related]  

  • 14. IL-4 receptor-directed cytotoxin for therapy of AIDS-associated KS tumors.
    Puri RK
    Drug News Perspect; 2000 Sep; 13(7):395-402. PubMed ID: 12937611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models.
    Strome SE; Kawakami K; Alejandro D; Voss S; Kasperbauer JL; Salomao D; Chen L; Maki RA; Puri RK
    Clin Cancer Res; 2002 Jan; 8(1):281-6. PubMed ID: 11801570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab' induce regression of subcutaneous human B-cell lymphoma in mice.
    Kreitman RJ; Hansen HJ; Jones AL; FitzGerald DJ; Goldenberg DM; Pastan I
    Cancer Res; 1993 Feb; 53(4):819-25. PubMed ID: 8428363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma.
    Kreitman RJ; Bailon P; Chaudhary VK; FitzGerald DJ; Pastan I
    Blood; 1994 Jan; 83(2):426-34. PubMed ID: 8286741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo studies of antitumor effects of the recombinant immunotoxin MSH-PE38KDEL on melanoma.
    Hui Q; Ma J; Song J; Liu Z; Ren H; Jiang W; Wang Y; Xu Y; Guo D; Zhang X; Lu S
    Neoplasma; 2014; 61(4):392-400. PubMed ID: 25027740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein.
    Joshi BH; Leland P; Silber J; Kreitman RJ; Pastan I; Berger M; Puri RK
    Br J Cancer; 2002 Jan; 86(2):285-91. PubMed ID: 11870521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
    Tulpule A; Joshi B; DeGuzman N; Espina BM; Mocharnuk R; Prakash O; Templeton D; Levine AM; Gill PS
    Ann Oncol; 1997 Jan; 8(1):79-83. PubMed ID: 9093711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.